News and updates
March 23, 2023
Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow Development and Manufacturing Programs
Collaboration marks the first global installation of Corning’s G1 production system to support higher-quality API-chemical production using inherently safer flow-chemistry technology
March 16, 2023
Curia Appoints Philip Macnabb as Chief Executive Officer
Philip Macnabb has been appointed as chief executive officer, succeeding John Ratliff. Macnabb joins Curia having spent years in leadership roles at various companies in the healthcare industry.
October 27, 2022
Curia Celebrates Ground-breaking Ceremony in Albuquerque
Construction begins on sterile fill-finish expansion for the production of vaccines and injectable medicines
August 2, 2022
Curia Appoints Niall Condon to Lead Manufacturing
Albany, NY – (BUSINESS WIRE) – Curia a leading contract research, development and manufacturing organization, today announced the appointment of Niall Condon as president of its Manufacturing Division, with immediate effect. Condon will drive gro...
June 9, 2022
Curia and Replicate Bioscience Enter Strategic Collaboration to Create Groundbreaking Development Platform for Self-Replicating RNA (srRNA)
ALBANY, N.Y.–(BUSINESS WIRE)–Curia a leading contract research, development and manufacturing organization, and Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer and to treat autoimmune and inflammatory disorder...
June 6, 2022
Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities
EMERYVILLE, Calif. & ALBANY, N.Y. –(BUSINESS WIRE)– Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia a leading contract research, development and manufacturing organization (CDMO), today announced Curia’s adoptio...
April 28, 2022
Curia completes “Center of Speed” expansion with new GMP suites
Curia, a leading global contract research, development, and manufacturing organization expands its small scale GMP-compliant capacity with the investment of new suites to support Orphan/Accelerated products with improved timeline, in-house analytical...
March 24, 2022
Curia Recognized on Forbes America’s Best Employers 2022 List
ALBANY, N.Y–(BUSINESS WIRE)–Curia a leading contract research, development, and manufacturing organization, today announced that it has been recognized on Forbes list of America’s Best Employers 2022, presented by Forbes and Statista Inc. The a...
March 9, 2022
Curia Enters Cooperative Agreement with U.S. Government to Expand Sterile Fill-Finish Capability
Additional High-Speed Line Adds BSL2 Capacity in the U.S.
February 14, 2022
Integrity Bio and LakePharma Become Curia
Companies Unite Under One Brand to Provide Seamless, Comprehensive Biologics Discovery, Development and Manufacturing Solutions
December 22, 2021
Curia Unveils Comprehensive mRNA Solution
Curia’s mRNA Services Combine Comprehensive Experience and Flexible Capabilities from Discovery Through Fill-Finish Manufacturing
September 2, 2021
Curia Completes Acquisition of LakePharma
ALBANY, N.Y.–(BUSINESS WIRE)–Curia a leading contract research, development and manufacturing organization, today announced it has completed the transaction to acquire LakePharma Inc., a privately held biologics drug discovery, clinical research...
Ready to move from idea to impact?
Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.